Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-14 6:49 pm Sale | 13G | TEMPEST THERAPEUTICS INC TPST | EcoR1 Capital LLC | 0 0% | -1,052,810 (Position Closed) | View |
| 2024-02-14 2:12 pm Sale | 13G | TEMPEST THERAPEUTICS INC TPST | Rock Springs Capital Management LP | 0 0% | -823,654 (Position Closed) | View |
| 2024-02-09 10:05 am Sale | 13G | TEMPEST THERAPEUTICS INC TPST | FMR LLC | 431,932 2.244% | -215,966 (-33.33%) | View |
| 2024-02-08 5:41 pm Unchanged | 13D | TEMPEST THERAPEUTICS INC TPST | Versant Venture Capital VI L.P. | 2,118,644 11% | 0 (Unchanged) | View |
| 2023-11-09 5:28 pm Unchanged | 13D | TEMPEST THERAPEUTICS INC TPST | Versant Venture Capital VI L.P. | 2,118,644 15.9% | 0 (Unchanged) | View |
| 2023-02-14 2:57 pm Unchanged | 13G | TEMPEST THERAPEUTICS INC TPST | Rock Springs Capital Management LP | 823,654 7.83% | 0 (Unchanged) | View |
| 2023-02-14 12:10 pm Purchase | 13G | TEMPEST THERAPEUTICS INC TPST | EcoR1 Capital LLC | 1,052,810 9.99% | 1,052,810 (New Position) | View |
| 2022-05-09 5:26 pm Purchase | 13D | TEMPEST THERAPEUTICS INC TPST | Versant Venture Capital VI L.P. | 2,118,644 20.5% | 940,173 (+79.78%) | View |
| 2022-02-17 4:19 pm Purchase | 13G | TEMPEST THERAPEUTICS INC TPST | LAV Regulus Ltd | 153,744 2.2% | 153,744 (New Position) | View |
| 2022-02-14 4:31 pm Sale | 13G | MILLENDO THERAPEUTICS INC MLND | Ikarian Capital LLC | 58,803 0.9% | -1,289,218 (-95.64%) | View |
| 2022-02-14 06:20 am Purchase | 13G | TEMPEST THERAPEUTICS INC TPST | ROCHE FINANCE LTD | 72,612 1.1% | 72,612 (New Position) | View |
| 2022-02-14 06:12 am Purchase | 13G | TEMPEST THERAPEUTICS INC TPST | CITADEL ADVISORS LLC | 365 0% | 365 (New Position) | View |
| 2022-02-10 7:41 pm Purchase | 13G | TEMPEST THERAPEUTICS INC TPST | Versant Venture Capital VI L.P. | 1,178,471 17.1% | 1,178,471 (New Position) | View |
| 2022-01-03 4:15 pm Purchase | 13G | TEMPEST THERAPEUTICS INC TPST | Rock Springs Capital Management LP | 823,654 11.48% | 513,493 (+165.56%) | View |
| 2021-07-15 4:31 pm Sale | 13G | TEMPEST THERAPEUTICS INC TPST | Rock Springs Capital Management LP | 310,161 4.67% | -331,994 (-51.70%) | View |
| 2021-07-08 4:25 pm Purchase | 13G | TEMPEST THERAPEUTICS INC TPST | Rock Springs Capital Management LP | 642,155 9.68% | 642,155 (New Position) | View |
| 2021-07-06 10:59 am Purchase | 13G | TEMPEST THERAPEUTICS INC TPST | FMR LLC | 647,898 9.764% | 647,898 (New Position) | View |
| 2021-04-13 10:06 am Unchanged | 13D | MILLENDO THERAPEUTICS INC MLND | New Enterprise Associates 15 L.P. | 1,766,407 9.3% | 0 (Unchanged) | View |
| 2021-04-07 5:25 pm Purchase | 13G | MILLENDO THERAPEUTICS INC MLND | Ikarian Capital LLC | 1,348,021 7.1% | 1,348,021 (New Position) | View |
| 2021-03-15 7:54 pm Purchase | 13G | MILLENDO THERAPEUTICS INC MLND | CITADEL ADVISORS LLC | 926,660 4.9% | 926,660 (New Position) | View |